EdgarLookup

LEXICON PHARMACEUTICALS, INC. — All Filings

1,003 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 4 4/A 424B2 424B3 424B4 424B5 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT FWP POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
ARS ANNLRPT 0001062822-26-000058 Mar 16, 2026 Dec 31, 2025
DEFA14A DEF 14A 0001062822-26-000057 Mar 16, 2026
DEF 14A DEF 14A 0001062822-26-000056 Mar 16, 2026
10-K 10-K 0001062822-26-000050 Mar 5, 2026 Dec 31, 2025
8-K 8-K 0001062822-26-000047 Mar 5, 2026
4 PRIMARY DOCUMENT 0001062822-26-000041 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000040 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000039 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000038 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000037 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000036 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000035 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000034 Mar 3, 2026 Feb 28, 2026
4 PRIMARY DOCUMENT 0001062822-26-000033 Feb 27, 2026 Feb 25, 2026
4 PRIMARY DOCUMENT 0001062822-26-000032 Feb 25, 2026 Feb 23, 2026
4 PRIMARY DOCUMENT 0001062822-26-000031 Feb 23, 2026 Feb 19, 2026
4 4 0001193125-26-059599 Feb 19, 2026 Feb 17, 2026
4 PRIMARY DOCUMENT 0001062822-26-000029 Feb 18, 2026 Feb 13, 2026
PRE 14A PRE 14A 0001062822-26-000027 Feb 17, 2026
4 PRIMARY DOCUMENT 0001062822-26-000026 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000025 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000024 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000023 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000022 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000021 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000020 Feb 17, 2026 Feb 12, 2026
4 PRIMARY DOCUMENT 0001062822-26-000019 Feb 17, 2026 Feb 12, 2026
D 0001193125-26-054545 Feb 17, 2026
3 3 0001193125-26-049458 Feb 12, 2026 Feb 2, 2026
FWP FWP 0001193125-26-041416 Feb 6, 2026
4 4 0001193125-26-037644 Feb 4, 2026 Feb 2, 2026
SCHEDULE 13D/A 0001193125-26-034176 Feb 2, 2026
8-K 8-K 0001193125-26-033793 Feb 2, 2026 Jan 29, 2026
424B5 424B5 0001193125-26-033160 Feb 2, 2026
FWP FWP 0001193125-26-030233 Jan 30, 2026
FWP FWP 0001193125-26-029894 Jan 30, 2026
8-K 8-K 0001193125-26-029514 Jan 29, 2026
424B5 424B5 0001193125-26-029498 Jan 29, 2026
8-K 8-K 0001193125-25-274383 Nov 10, 2025 Nov 6, 2025
424B5 424B5 0001193125-25-270167 Nov 6, 2025
8-K 8-K 0001193125-25-270020 Nov 6, 2025
10-Q 10-Q 0001062822-25-000054 Nov 6, 2025 Sep 30, 2025
8-K 8-K 0001062822-25-000049 Nov 6, 2025
S-8 S-8 0001628280-25-038387 Aug 6, 2025
10-Q 10-Q 0001628280-25-038340 Aug 6, 2025 Jun 30, 2025
8-K 8-K 0001062822-25-000042 Aug 6, 2025
8-K 8-K 0001062822-25-000037 Jul 28, 2025 Jul 23, 2025
SCHEDULE 13G/A 0000315066-25-001680 Jul 8, 2025
8-K 8-K 0001062822-25-000035 Jul 3, 2025
3 PRIMARY DOCUMENT 0001127602-25-017051 Jun 9, 2025 Jun 1, 2025